Precision Oncology in HER2-Mutated NSCLC: Strategies for Today and Tomorrow

<p>Are you up to date on the evolving treatment landscape for <em>HER2</em>-mutated non-small cell lung cancer (NSCLC)? Do you know the role of novel targeted therapies?</p> <p>Credit available for this activity expires: 12/24/2026<br /> Earn Credit / Learning Objectives & Disclosures: <a href= "https://www.medscape.org/viewarticle/precision-oncology-her2-mutated-nsclc-strategies-today-and-2025a100105r?ecd=bdc_podcast_libsyn_mscpedu" target="_blank" rel= "noopener">https://www.medscape.org/viewarticle/precision-oncology-her2-mutated-nsclc-strategies-today-and-2025a100105r?ecd=bdc_podcast_libsyn_mscpedu</a></p>